About RetInSight
RetInSight is a Healthcare company based in Vienna (Austria) founded in 2020 by Amir Sadeghipour, Hans Peter Schwarz, and Corinna Zur Bonsen-Thomas, and was acquired by Topconhealthcare in May 2025. AI-based platform for diagnosis of eye disease. Its chief executive, as recorded, is Corinna Zur Bonsen-Thomas. RetInSight offers products and services including GA Monitor and Fluid Monitor. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is RetInSight GmbH.
Company details
RetInSight was established in 2020 in Vienna, Austria, within the healthcare technology sector. An AI-driven platform has been created for diagnosing eye diseases, focusing on intraretinal and subretinal fluid localization and quantification. These solutions support diagnosis, prognosis, and therapy guidance. Deep learning is employed to connect a mobile app with PACSEMR systems and imaging devices, enabling integrated operations.
- Headquarters Vienna, Austria
- Founders Amir Sadeghipour, Hans Peter Schwarz, Corinna Zur Bonsen-Thomas
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website retinsight.com
- Social LinkedIn
- Acquired by Topconhealthcare (May 2025)
- Legal Name Retinsight Gmbh
- Latest Funding Round$1.23M (USD), Grant
Jan 2024
- InvestorsEuropean Union
& 1 more
- Acquired byTopconhealthcare
(May 2025)
Products & Services of RetInSight
RetInSight offers a comprehensive portfolio of products and services, including GA Monitor and Fluid Monitor.
AI tool for assessing Geographic Atrophy in retinal diseases
AI for quantifying fluids in eye disease treatment
Funding Insights of RetInSight
- Total Rounds 1
- Last Round Grant — $1.23M
- First Round $1.23M
(Jan 2024)
- Investors Count 1
All 1 funding rounds of RetInSight with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $1.23M | Grant | – | – |
2 investors in total: 2 institutional.
Investors in RetInSight
RetInSight has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Topconhealthcare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Offers medical devices and software for ophthalmic diagnostics and patient care. | 1932 | topconhealthcare.com | Oakland, United States |
Investor details for RetInSight
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of RetInSight
3 people are tracked at RetInSight (3 in leadership).
| Name | Role | Group |
|---|---|---|
Amir Sadeghipour | Co-Founder | Leadership |
Hans Peter Schwarz | Co-Founder | Leadership |
Corinna Zur Bonsen-Thomas | Co-Founder & CEO | Leadership |
Complete people profiles for RetInSight
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of RetInSight
3 dated milestones of RetInSight across 5 years, from founding to its latest funding, stage changes and deals.
- Founded RetInSight is founded.
- Funding First funding round of $1.2M.
- Exit Acquired by Topconhealthcare.
Web traffic of RetInSight
The website of RetInSight (retinsight.com) receives about 3.6K visits a month.
- Monthly visits3.6K
▼ 2.7% vs previous month
Websites whose visitors overlap most with RetInSight. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| retinai.com | 100% | 5.8K | #3,370,310 | View details | |
| useocular.com | 98% | 5.8K | #3,743,270 | View details | |
| eyenuk.com | 97% | 5.7K | #3,436,821 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Retinsight
Complete news archive for RetInSight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RetInSight
RetInSight was founded in 2020 and raised its 1st funding round 4 years after it was founded.
RetInSight is headquartered in Vienna, Austria.
Corinna Zur Bonsen-Thomas is the CEO of RetInSight, as recorded in our data. They have also founded this company.
RetInSight was established in 2020 in Vienna, Austria, within the healthcare technology sector. An AI-driven platform has been created for diagnosing eye diseases, focusing on intraretinal and subretinal fluid localization and quantification. These solutions support diagnosis, prognosis, and therapy guidance. Deep learning is employed to connect a mobile app with PACSEMR systems and imaging devices, enabling integrated operations.
RetInSight offers GA Monitor and Fluid Monitor.
RetInSight has 2 investors. Key investors include European Union, and Topconhealthcare.
RetInSight operates through Retinsight Gmbh.
Yes. RetInSight was acquired by Topconhealthcare in May 2025.